Pharmaceutical

NanoSyrinx secures funds to develop biologic therapeutics

NanoSyrinx has secured £10m ($13m) aimed at advancing its technology for targeted intracellular delivery of biologic therapeutics.

Sep 12, 2024 - 04:00
NanoSyrinx secures funds to develop biologic therapeutics
NanoSyrinx has secured £10m ($13m) aimed at advancing its technology for targeted intracellular delivery of biologic therapeutics.
Read the original article

Tags:

Previous Article

EASD 2024: Novo Nordisk’s Saxenda shows weight loss in children

Next Article

FDA grants breakthrough therapy status to Arrowhead’s plozasiran

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Zucara Therapeutics receives FDA IND approval for ZT-01

Zucara Therapeutics receives FDA IND approval for ZT-01

Apr 20, 2023

Signal: PureHealth UK expansion shows continued focus on healthcare in UAE

Signal: PureHealth UK expansion shows continued focus o...

Aug 30, 2023

Orchard secures FDA fast track designation for Hurler syndrome gene therapy

Orchard secures FDA fast track designation for Hurler s...

Dec 2, 2023